AI, Big Data will be the most impactful emerging technologies for pharma in 2023: GlobalData Read more
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets Read more
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more